EVP – S&M 2 · Perspective Therapeutics, Inc. (CATX)

Michael Krachon

A named executive officer of Perspective Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$345,142

Salary $243,338Stock awards $0

FY2019: $326,833

2nd of 4 named executive officers at Perspective Therapeutics by FY2020 total.

4 named officers on file for Perspective Therapeutics, FY2020

Michael Krachon’s pay file — $29

  • 4 fiscal years of pay, line by line
  • CATX’s disclosed peer group of 25 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Perspective Therapeutics’s whole pay program stands against its peers

  • Perspective Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CATX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 27, 2020 (DEF 14A).

Free

Get Michael Krachon’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Krachon compensation by year

Perspective Therapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Perspective Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020
Salary$225,000$236,250$243,338$243,338
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$103,815$50,325$44,820$59,220
Non-equity incentive$9,000$28,350$12,167$42,584
Pension and deferred compensation$0$0$0$0
All other$0$0$26,508$0
Total$337,815$314,925$326,833$345,142

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed October 27, 2020, accession 0001437749-20-021715, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0001437749-20-021715. Every figure is read from that document and cited to the page and table it appears in. Filed October 27, 2020.

$338K
$315K
$327K
$345K
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option75,000—$0.43
Option37,500—$0.46

Per the Outstanding Equity Awards at Fiscal Year-End table in Perspective Therapeutics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Perspective Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Lori WoodsCEO and Director$491,637
Michael Krachon · this pageEVP – S&M 2$345,142
William CavanaghCRDO$318,021
Jennifer StreeterCOO and VP of HR$312,285

The full Perspective Therapeutics compensation record

free company brief

This page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Perspective Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Krachon's compensation dossier · One-time report. No refunds.